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Proteomics goes parallel 
 
Massively parallel sequencing of peptides could signal a new era of high-throughput 
proteomics. 
 
 
Ben C. Collins1 and Ruedi Aebersold1, 2 
1Department of Biology, Institute of Molecular Systems Biology, ETH Zurich and 2Faculty of 
Science, University of Zurich, Zurich, Switzerland 
 
 
Proteomics has yet to attain the power of genomics and transcriptomics. The impressive 
performance of technologies for nucleic-acid sequencing rests on massively parallel 
measurements of short oligonucleotides, using fluorescence as a readout. In this issue, 
Swaminathan et al.1 demonstrate that parallel fluorescence sequencing is also achievable 
for peptides. Their innovative method combines elements of classic protein chemistry with 
features of the optical systems used in nucleic-acid sequencing. Although further 
optimization is needed, the study fascinates with the prospect of a generally accessible, 
reliable, and truly universal proteomic technology. 
 
Proteins are indispensible to living systems in their roles as chemical catalysts, 
structural components, and mediators of physiological processes. The ability to accurately 
identify and quantify proteins would greatly contribute to the understanding of biology. 
Today, proteomes are frequently predicted or inferred from transcriptomes. It is well 
documented that the dependency between protein and mRNA levels is complex, and that 
predicting one from the other is imprecise and unreliable2. Why then are necessarily 
imprecise predictions from mRNA preferred over direct protein measurements in many 
instances? The answer lies in the state and accessibility of the respective measurement 
techniques: whereas essentially complete transcriptome analysis is readily available to 
biologists via core facility and commercial providers, proteome analysis is still most 
effectively performed by expert labs and cannot easily reach the throughput, robustness 
and reproducibility of transcriptome analysis.  
The first generation of DNA sequencers, which produced groundbreaking genome 
maps, was based on sequential sequencing of isolated DNA segments—an intrinsically slow 
and expensive process even with automation. Widely accessible genomic analysis became 
possible only with the development of methods that sequence millions of nucleic acid 
segments in parallel3, allowing complete genomic maps to be generated at high throughput 
and coverage and at  low  cost.  These commercially well-supported techniques have 
transformed biomedical research and become a mainstay of experimental biology. 
 
Although ‘top down’ proteomics approaches are emerging4, proteins have 
traditionally been quantified and sequenced using ‘bottom up’ methods. As in genomics, 
these methods analyze constituent segments—in this case, peptides generated by 
enzymatic cleavage of proteins. In the 1950s, Pehr Edman invented a cyclic process of 
chemical reactions, known as Edman degradation5, to determine the amino acid sequence 
of peptides. It consists of the coupling of phenyl isothiocyanate to accessible amino groups 
followed by release of the derivatized N-terminal amino acid from the peptide chain, 
generating a new N-terminus. The released amino acid is identified, and the process is 
repeated to establish the peptide sequence. The Edman process is slow and requires large 
amounts of highly purified peptides. Yet, essentially all protein sequences known until the 
early 1990s were determined with this process.  
 
In the 1990s, mass spectrometry (MS) became the method of choice for protein 
sequencing, leaving Edman degradation in the realm of science history. MS techniques to 
infer protein identity and quantity from measurements of the mass to charge ratio and 
fragmentation pattern of peptide segments have become highly sophisticated, powerful and 
versatile, and thus widely used6. Emulating the path of genomics, these techniques have 
progressed from manual sequencing of specific oligomers, to automated, sequential 
sequencing of peptides at high throughput, to parallel sequencing of multiple peptides by 
means of data-independent analyses7,8, exemplified by SWATH-MS9. Although their 
throughput, accuracy and reproducibility are remarkable, the goal of routine, complete 
proteome quantification of large sample cohorts, akin to genomic analyses, has remained 
elusive.  
 
It is conceivable that continued advances within the current framework of data-
independent-acquisition MS will eventually achieve a performance on par with genomics. 
But it is also possible that a full account of the complexity and depth of proteomes will 
require disruptive new technologies. Although nanopore sequencing of proteins has shown 
promise10, the peptide fluorosequencing method of Swaminathan et al.1 appears to be the 
most advanced example of such a disruptive approach with a clear path to routine use. It is 
a marriage across the ages—between the largely forgotten Edman degradation chemistry 
and the principles of massively parallel-in-space fluorescence imaging developed for next-
generation DNA sequencing (Fig. 1).  
 
The first step of the new method is to generate an array of sequencing substrates by 
fluorescently labeling peptides at specific amino acid side chains and immobilizing them at 
their C-termini in the flow cell of a sequencing system. The immobilized peptides are then 
subjected to Edman degradation steps in parallel, and after each step the ensemble of 
immobilized substrates is imaged. In contrast to classic Edman degradation, in which the 
phenylthiohydantoin–amino acid conjugates eliminated at each step are identified, the 
stepwise degradation serves simply as a register to measure the decrease of fluorescence 
intensity caused by elimination of a labeled amino acid. The sequence of each immobilized 
substrate is inferred by relating the constraints derived from the observed fluorescence 
patterns to a protein sequence database using a sophisticated software tool developed for 
this purpose.   
In this study the authors have taken the first steps towards feasibility of peptide 
fluorosequencing. Specifically, they (i) describe an imaging system compatible with the 
harsh conditions associated with the Edman degradation chemistry, (ii) demonstrate 
determination of the precise position of fluorescently labeled lysine or cysteine residues in 
model peptides, (iii) characterize sources of error and inefficiencies in the system, (iv) 
simulate the potential to identify proteins from more complex proteomes and provide a 
computational framework to infer peptide sequences from the observed fluorescent 
patterns, and (v) demonstrate the localization of a particular phosphorylated serine residue 
from a peptide containing multiple serines. 
 
The peptide fluorosequencing method of Swaminathan et al.1 is exciting because it 
highlights a clear path toward peptide, and conceivably protein, sequencing at very high 
throughput and reproducibility and potentially low cost. A substantial advantage of the 
system is that it capitalizes on a collection of well-characterized processes from other 
strategies (Edman chemistry, massively parallel DNA sequencing, and MS-based 
computational strategies for sequence database searching) that may speed maturation from 
proof-of-concept to a routinely applicable method. Furthermore, the data generated by the 
method should bear some resemblance to the data produced by its massively parallel 
antecedents in the world of genomics and transcriptomics. This could accelerate the 
adoption of peptide fluorosequencing by the broader biological community, in contrast to 
MS-based proteomics technologies, whose uptake has arguably been slowed by their 
technical and computational difficulty.  
 
As Swaminathan et al.1 note, several technical and conceptual challenges must be 
overcome before the method can reach its full potential. The issues are mainly rooted in the 
nature of Edman chemistry and the complexity of the human proteome, and include the 
following: (i) even at the yield per degradation step shown in the paper (91-97%), the length 
of achievable peptide sequences is limited; (ii) because the sequencing yield is sequence 
dependent, challenging sequences, such as proline-rich stretches, may obscure the 
sharpness of the fluorescent patterns; (iii) the number of functional groups accessible to 
fluorescent labeling is limited to the chemically reactive groups in peptides, predominantly 
amino, carboxyl and sulfhydryl groups, thus capping the information content of the 
fluorescence patterns; (iv) modified residues will generally not be recognized unless they 
are specifically fluorescently labeled, and a specific labeling chemistry is known for only a 
small subset of modifications; (v) the large dynamic range of the human cellular proteome 
(~107), along with the high number of peptides generated per protein by enzymatic 
digestion (~102) and the large number of open reading frames expressed per cell (~104) 
constitute an enormous analytical challenge, even disregarding proteoform diversity. For 
peptide fluorosequencing, meeting these challenges requires a level of substrate 
multiplexing that has not yet been achieved. Although the system implemented by the 
authors is limited to the analysis of relatively simple sample mixtures, the path forward 
seems well laid out and is certainly one worth taking.   
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Figure 1 
Peptide fluorosequencing as described by Swaminathan et al.1. Complex peptide mixtures, 
most likely derived from enzymatic or chemical cleavage of protein extracts, are labeled 
with different fluorophores for each amino acid residue (left). In this case, we depict a 2-
color scheme where lysine and cysteine residues are labeled with distinct fluorophores. The 
labeled peptides are immobilized at their C-terminus using amide linkage to aminosilanes on 
a glass cover slip. The peptides are then subjected to iterative cycles of cleavage of the N-
terminal amino acid residue by the Edman degradation and fluorescence imaging (center). 
The fluorescence intensity at each location (i.e. peptide) is tracked as a function of Edman 
cycles. The pattern of fluorescence intensity drops is interpreted to provide a partial 
sequence annotation for each peptide, which can be matched and scored against a protein 
sequence database to infer the most likely set of proteins present in the sample (right).  
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